{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:43:07Z","timestamp":1794004987553,"version":"4.8.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Shandong Provincial Medical Association Research Project","award":["YXH2024YS050"],"award-info":[{"award-number":["YXH2024YS050"]}]},{"name":"the Natural Science Youth Foundation of Shandong Province","award":["ZR2023QG014"],"award-info":[{"award-number":["ZR2023QG014"]}]},{"name":"the Shandong-Chongqing Science and Technology Cooperation Project","award":["2024LYXZ021"],"award-info":[{"award-number":["2024LYXZ021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04120-6","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:20Z","timestamp":1752537620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Machine learning survival models for Non-alcoholic fatty liver disease based on a health checkup cohort"],"prefix":"10.1186","volume":"25","author":[{"given":"Hongyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"issue":"4","key":"4120_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/hep.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335\u201347. https:\/\/doi.org\/10.1097\/hep.0000000000000004. PMID: 36626630.","journal-title":"Hepatology"},{"issue":"4","key":"4120_CR2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jhep.2021.05.022","volume":"75","author":"P Golabi","year":"2021","unstructured":"Golabi P, Paik JM, AlQahtani S, Younossi Y, Tuncer G, Younossi ZM. Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009\u20132019. J Hepatol. 2021;75(4):795\u2013809. https:\/\/doi.org\/10.1016\/j.jhep.2021.05.022. PMID: 34081959.","journal-title":"J Hepatol"},{"issue":"12","key":"4120_CR3","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1016\/j.cgh.2021.12.01","volume":"20","author":"P Golabi","year":"2022","unstructured":"Golabi P, Paik JM, Harring M, Younossi E, Kabbara K, Younossi ZM. Prevalence of High and Moderate Risk Nonalcoholic Fatty Liver Disease Among Adults in the United States, 1999\u20132016. Clin Gastroenterol Hepatol. 2022;20(12):2838-47.e7. https:\/\/doi.org\/10.1016\/j.cgh.2021.12.01. PMID: 34929391.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"4120_CR4","doi-asserted-by":"publisher","first-page":"e0251","DOI":"10.1097\/hc9.0000000000000251","volume":"7","author":"JM Paik","year":"2023","unstructured":"Paik JM, Henry L, Younossi Y, Ong J, Alqahtani S, Younossi ZM. The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019. Hepatol Commun. 2023;7(10):e0251. https:\/\/doi.org\/10.1097\/hc9.0000000000000251. PMID: 02009842-202310010-00041.","journal-title":"Hepatol Commun"},{"issue":"4","key":"4120_CR5","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.cgh.2020.05.009","volume":"19","author":"Z Wang","year":"2021","unstructured":"Wang Z, Zhao X, Chen S, Wang Y, Cao L, Liao W, et al. Associations Between Nonalcoholic Fatty Liver Disease and Cancers in a Large Cohort in China. Clin Gastroenterol Hepatol. 2021;19(4):788-96.e4. https:\/\/doi.org\/10.1016\/j.cgh.2020.05.009. PMID: 32407969.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"4120_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.7861\/clinmedicine.7-2-119","volume":"7","author":"S Whalley","year":"2007","unstructured":"Whalley S, Puvanachandra P, Desai A, Kennedy H. Hepatology outpatient service provision in secondary care: a study of liver disease incidence and resource costs. Clin Med (Lond). 2007;7(2):119\u201324. https:\/\/doi.org\/10.7861\/clinmedicine.7-2-119. PMID: 17491498.","journal-title":"Clin Med (Lond)"},{"key":"4120_CR7","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62:S47-64. https:\/\/doi.org\/10.1016\/j.jhep.2014.12.012. PMID: 25920090.","journal-title":"J Hepatol"},{"issue":"1","key":"4120_CR8","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s12916-023-03080-6","volume":"21","author":"Y Jia","year":"2023","unstructured":"Jia Y, Li D, You Y, Yu J, Jiang W, Liu Y, et al. Multi-system diseases and death trajectory of metabolic dysfunction-associated fatty liver disease: findings from the UK Biobank. BMC Med. 2023;21(1):398. https:\/\/doi.org\/10.1186\/s12916-023-03080-6. PMID: 37864216.","journal-title":"BMC Med"},{"issue":"5","key":"4120_CR9","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"K Cusi","year":"2022","unstructured":"Cusi K, Isaacs S, Barb D, Basu R, Caprio S, Garvey WT, et al. American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD). Endocr Pract. 2022;28(5):528\u201362. https:\/\/doi.org\/10.1016\/j.eprac.2022.03.010. PMID: 35569886.","journal-title":"Endocr Pract"},{"issue":"5","key":"4120_CR10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.7861\/clinmed.2020-0696","volume":"20","author":"W Li","year":"2020","unstructured":"Li W, Alazawi W. Non-alcoholic fatty liver disease. Clin Med (Lond). 2020;20(5):509\u201312. https:\/\/doi.org\/10.7861\/clinmed.2020-0696. PMID: 32934047.","journal-title":"Clin Med (Lond)"},{"issue":"2","key":"4120_CR11","doi-asserted-by":"publisher","first-page":"e223146","DOI":"10.1148\/radiol.223146","volume":"309","author":"A Ozturk","year":"2023","unstructured":"Ozturk A, Kumar V, Pierce TT, Li Q, Baikpour M, Rosado-Mendez I, et al. The Future Is Beyond Bright: The Evolving Role of Quantitative US for Fatty Liver Disease. Radiology. 2023;309(2):e223146. https:\/\/doi.org\/10.1148\/radiol.223146. PMID: 37934095.","journal-title":"Radiology"},{"issue":"1","key":"4120_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12916-017-0806-8","volume":"15","author":"BA Neuschwander-Tetri","year":"2017","unstructured":"Neuschwander-Tetri BA. Non-alcoholic fatty liver disease. BMC Med. 2017;15(1):45. https:\/\/doi.org\/10.1186\/s12916-017-0806-8. PMID: 28241825.","journal-title":"BMC Med"},{"issue":"2","key":"4120_CR13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/med4.62","volume":"2","author":"GM Raj","year":"2024","unstructured":"Raj GM, Dananjayan S, Gudivada KK. Applications of artificial intelligence and machine learning in clinical medicine: what Lies ahead? Med Adv. 2024;2(2):202\u20134. https:\/\/doi.org\/10.1002\/med4.62.","journal-title":"Med Adv"},{"issue":"3","key":"4120_CR14","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/med4.70","volume":"2","author":"H Yuan","year":"2024","unstructured":"Yuan H, Kang L, Li Y, Fan Z. Human-in-the-loop machine learning for healthcare: current progress and future opportunities in electronic health records. Med Adv. 2024;2(3):318\u201322. https:\/\/doi.org\/10.1002\/med4.70.","journal-title":"Med Adv"},{"key":"4120_CR15","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fpubh.2020.00220","volume":"8","author":"X Pan","year":"2020","unstructured":"Pan X, Xie X, Peng H, Cai X, Li H, Hong Q, et al. Prediction for Non-alcoholic Fatty Liver Disease Based on Biochemical and Dietary Variables in a Chinese Han Population. Front Public Health. 2020;8:220. https:\/\/doi.org\/10.3389\/fpubh.2020.00220. PMID: 32714888.","journal-title":"Front Public Health"},{"key":"4120_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s10916-020-01693-5","volume":"45","author":"O Goldman","year":"2021","unstructured":"Goldman O, Ben-Assuli O, Rogowski O, Zeltser D, Shapira I, Berliner S, et al. Non-alcoholic Fatty Liver and Liver Fibrosis Predictive Analytics: Risk Prediction and Machine Learning Techniques for Improved Preventive Medicine. J Med Syst. 2021;45:2\u201322. https:\/\/doi.org\/10.1007\/s10916-020-01693-5. PMID: 33426569.","journal-title":"J Med Syst"},{"issue":"1","key":"4120_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s12876-022-02401-y","volume":"22","author":"KWM Abeysekera","year":"2022","unstructured":"Abeysekera KWM, Orr JG, Gordon FH, Howe LD, Hamilton-Shield J, Heron J, et al. Evaluating future risk of NAFLD in adolescents: a prediction and decision curve analysis. BMC Gastroenterol. 2022;22(1):323. https:\/\/doi.org\/10.1186\/s12876-022-02401-y. PMID: 35773644.","journal-title":"BMC Gastroenterol"},{"key":"4120_CR18","doi-asserted-by":"publisher","first-page":"e46891","DOI":"10.2196\/46891","volume":"25","author":"G Huang","year":"2023","unstructured":"Huang G, Jin Q, Mao Y. Predicting the 5-Year Risk of Nonalcoholic Fatty Liver Disease Using Machine Learning Models: Prospective Cohort Study. J Med Internet Res. 2023;25:e46891. https:\/\/doi.org\/10.2196\/46891. PMID: 37698911.","journal-title":"J Med Internet Res"},{"issue":"8","key":"4120_CR19","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1002\/jum.16194","volume":"42","author":"A Tahmasebi","year":"2023","unstructured":"Tahmasebi A, Wang S, Wessner CE, Vu T, Liu JB, Forsberg F, et al. Ultrasound-Based Machine Learning Approach for Detection of Nonalcoholic Fatty Liver Disease. J Ultrasound Med. 2023;42(8):1747\u201356. https:\/\/doi.org\/10.1002\/jum.16194. PMID: 36807314.","journal-title":"J Ultrasound Med"},{"key":"4120_CR20","volume-title":"Random survival forests","author":"I Hemant","year":"2008","unstructured":"Hemant I, Udaya BK, Eugene HB, Michael SL. Random survival forests. Wiley StatsRef: Statistics Reference Online; 2008."},{"issue":"2","key":"4120_CR21","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jtcvs.2022.05.046","volume":"165","author":"D Tian","year":"2023","unstructured":"Tian D, Yan HJ, Shiiya H, Sato M, Shinozaki-Ushiku A, Nakajima J. Machine learning-based radiomic computed tomography phenotyping of thymic epithelial tumors: Predicting pathological and survival outcomes. J Thorac Cardiovasc Surg. 2023;165(2):502-16.e9. https:\/\/doi.org\/10.1016\/j.jtcvs.2022.05.046. PMID: 36038386.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"4120_CR22","doi-asserted-by":"publisher","unstructured":"Fan JG, Jia JD, Li YM, Wang BY, Lu LG, Shi JP et al. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology. 2010; 18:163\u2013166). J Dig Dis. 2011;12(1):38\u201344. https:\/\/doi.org\/10.1111\/j.1751-2980.2010.00476.x. PMID: 21276207.","DOI":"10.1111\/j.1751-2980.2010.00476.x"},{"issue":"2","key":"4120_CR23","first-page":"25","volume":"7","author":"I Hemant","year":"2007","unstructured":"Hemant I, Udaya BK. Random survival forests for R. R News. 2007;7(2):25\u201331.","journal-title":"R News"},{"key":"4120_CR24","doi-asserted-by":"publisher","unstructured":"Spytek M, Krzyzi\u0144ski M, Langbein SH, Baniecki H, Wright MN, Biecek P. survex: an R package for explaining machine learning survival models. Bioinformatics. 2023;39(12):btad723. https:\/\/doi.org\/10.1093\/bioinformatics\/btad723. PMID: 38039146.","DOI":"10.1093\/bioinformatics\/btad723"},{"issue":"4","key":"4120_CR25","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.pan.2023.04.009","volume":"23","author":"W Chen","year":"2023","unstructured":"Chen W, Zhou B, Jeon CY, Xie F, Lin YC, Butler RK, et al. Machine learning versus regression for prediction of sporadic pancreatic cancer. Pancreatology. 2023;23(4):396\u2013402. https:\/\/doi.org\/10.1016\/j.pan.2023.04.009. PMID: 37130760.","journal-title":"Pancreatology"},{"key":"4120_CR26","doi-asserted-by":"publisher","unstructured":"Ng\u2019andu NH. An empirical comparison of statistical tests for assessing the proportional hazards assumption of Cox\u2019s model. Stat Med. 1997;16(6):611\u201326.\u00a0https:\/\/doi.org\/10.1002\/(sici)1097-0258(19970330)16:6%3C;611::aid-sim437%3E;3.0.co;2-t. PMID: 9131751.","DOI":"10.1002\/(sici)1097-0258(19970330)16:6%3C;611::aid-sim437%3E;3.0.co;2-t"},{"issue":"3","key":"4120_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/aje\/kwh201","volume":"160","author":"RW Platt","year":"2004","unstructured":"Platt RW, Joseph KS, Ananth CV, Grondines J, Abrahamowicz M, Kramer MS. A proportional hazards model with time-dependent covariates and time-varying effects for analysis of fetal and infant death. Am J Epidemiol. 2004;160(3):199\u2013199. https:\/\/doi.org\/10.1093\/aje\/kwh201. PMID: 15257989.","journal-title":"Am J Epidemiol"},{"issue":"12","key":"4120_CR28","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1097\/JTO.0b013e318233d835","volume":"6","author":"JM Taylor","year":"2011","unstructured":"Taylor JM. Random Survival Forests. J Thorac Oncol. 2011;6(12):1974\u20135. https:\/\/doi.org\/10.1097\/JTO.0b013e318233d835. PMID: 22088987.","journal-title":"J Thorac Oncol"},{"key":"4120_CR29","doi-asserted-by":"publisher","unstructured":"Wang H, Li G. A Selective Review on Random Survival Forests for High Dimensional Data. Quant Biosci. 2017;36(2):85\u201396. https:\/\/doi.org\/10.22283\/qbs.2017.36.2.85. PMID: 30740388.","DOI":"10.22283\/qbs.2017.36.2.85"},{"key":"4120_CR30","first-page":"44","volume":"5","author":"B-H Imad","year":"2011","unstructured":"Imad B-H, Denis L, Hatem B-A. A review of survival trees. Stat Surv. 2011;5:44\u201371.","journal-title":"Stat Surv"},{"key":"4120_CR31","doi-asserted-by":"publisher","unstructured":"Lin J, Yin M, Liu L, Gao J, Yu C, Liu X et al. The Development of a Prediction Model Based on Random Survival Forest for the Postoperative Prognosis of Pancreatic Cancer: A SEER-Based Study. Cancers (Basel). 2022;14(19). https:\/\/doi.org\/10.3390\/cancers14194667. PMID: 36230593.","DOI":"10.3390\/cancers14194667"},{"issue":"1","key":"4120_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12911-023-02293-2","volume":"23","author":"Y Wang","year":"2023","unstructured":"Wang Y, Deng Y, Tan Y, Zhou M, Jiang Y, Liu B. A comparison of random survival forest and Cox regression for prediction of mortality in patients with hemorrhagic stroke. BMC Med Inform Decis Mak. 2023;23(1):215. https:\/\/doi.org\/10.1186\/s12911-023-02293-2. PMID: 37833724.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"5","key":"4120_CR33","doi-asserted-by":"publisher","first-page":"e2312022","DOI":"10.1001\/jamanetworkopen.2023.12022","volume":"6","author":"D Tian","year":"2023","unstructured":"Tian D, Yan HJ, Huang H, Zuo YJ, Liu MZ, Zhao J, et al. Machine learning-based prognostic model for patients after lung transplantation. JAMA Netw Open. 2023;6(5):e2312022. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.12022. PMID: 37145595.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"4120_CR34","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jhep.2005.02.042","volume":"43","author":"JG Fan","year":"2005","unstructured":"Fan JG, Zhu J, Li XJ, Chen L, Li L, Dai F, et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol. 2005;43(3):508\u201314. https:\/\/doi.org\/10.1016\/j.jhep.2005.02.042. PMID: 16006003.","journal-title":"J Hepatol"},{"issue":"2","key":"4120_CR35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jacl.2015.11.017","volume":"10","author":"MH Yang","year":"2016","unstructured":"Yang MH, Sung J, Gwak GY. The associations between apolipoprotein B, A1, and the B\/A1 ratio and nonalcoholic fatty liver disease in both normal-weight and overweight Korean population. J Clin Lipidol. 2016;10(2):289\u201398. https:\/\/doi.org\/10.1016\/j.jacl.2015.11.017. PMID: 27055959.","journal-title":"J Clin Lipidol"},{"issue":"2","key":"4120_CR36","first-page":"74","volume":"22","author":"CO Aransiola","year":"2024","unstructured":"Aransiola CO, Balogun WO. Non-alcoholic fatty liver disease and relationship with adiposity, in nigerian patients with type 2 diabetes mellitus: the Ibadan experience. Ann Ib Postgrad Med. 2024;22(2):74\u201380 PMID: 40007722.","journal-title":"Ann Ib Postgrad Med"},{"issue":"1","key":"4120_CR37","doi-asserted-by":"publisher","first-page":"18547","DOI":"10.1038\/s41598-024-69411-6","volume":"14","author":"Y Huang","year":"2024","unstructured":"Huang Y, Jin T, Ni W, Zhou Y, Zhang R, Li D, et al. Baseline and change in serum lipid and uric acid level over time and incident of nonalcoholic fatty liver disease (NAFLD) in Chinese adults. Sci Rep. 2024;14(1):18547. https:\/\/doi.org\/10.1038\/s41598-024-69411-6. PMID: 39122810.","journal-title":"Sci Rep"},{"issue":"12","key":"4120_CR38","doi-asserted-by":"publisher","first-page":"e0279274","DOI":"10.1371\/journal.pone.0279274","volume":"17","author":"X Dai","year":"2022","unstructured":"Dai X, Zhou G, Xu L. Associations between red blood cell count and metabolic dysfunction-associated fatty liver disease(MAFLD). PLoS One. 2022;17(12):e0279274. https:\/\/doi.org\/10.1371\/journal.pone.0279274. PMID: 36574367.","journal-title":"PLoS One"},{"issue":"12","key":"4120_CR39","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1007\/s40618-022-01848-w","volume":"45","author":"C Tong","year":"2022","unstructured":"Tong C, Li Q, Kong L, Ni X, Halengbieke A, Zhang S, et al. Sex-specific metabolic risk factors and their trajectories towards the non-alcoholic fatty liver disease incidence. J Endocrinol Invest. 2022;45(12):2233\u201345. https:\/\/doi.org\/10.1007\/s40618-022-01848-w.","journal-title":"J Endocrinol Invest"},{"key":"4120_CR40","doi-asserted-by":"publisher","first-page":"8867985","DOI":"10.1155\/2021\/8867985","volume":"2021","author":"A Michalak","year":"2021","unstructured":"Michalak A, Cicho\u017c-Lach H, Guz M, Kozicka J, Cybulski M, Jeleniewicz W. Plateletcrit and Mean Platelet Volume in the Evaluation of Alcoholic Liver Cirrhosis and Nonalcoholic Fatty Liver Disease Patients. Biomed Res Int. 2021;2021:8867985. https:\/\/doi.org\/10.1155\/2021\/8867985. PMID: 33644233.","journal-title":"Biomed Res Int"},{"issue":"1","key":"4120_CR41","doi-asserted-by":"publisher","first-page":"13877","DOI":"10.1038\/s41598-022-17511-6","volume":"12","author":"D Li","year":"2022","unstructured":"Li D, Zhang M, Wu S, Tan H, Li N. Risk factors and prediction model for nonalcoholic fatty liver disease in northwest China. Sci Rep. 2022;12(1):13877. https:\/\/doi.org\/10.1038\/s41598-022-17511-6. PMID: 35974018.","journal-title":"Sci Rep"},{"issue":"7","key":"4120_CR42","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology. 2020;158(7):1999-2014.e1. https:\/\/doi.org\/10.1053\/j.gastro.2019.11.312. PMID: 32044314.","journal-title":"Gastroenterology"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04120-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04120-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04120-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:22Z","timestamp":1752537622000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04120-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4120"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04120-6","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was approved by the Ethics Committee of the First Affiliated Hospital of Shandong First Medical University (2021S128) and written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"518"}}